top of page
Executive Spotlights

NeuroBo Pharmaceuticals Welcomes Hyung Heon Kim as New CEO and President

Boston, MA, August 14, 2023 (PRNewswire) -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology firm dedicated to revolutionizing the landscape of cardiometabolic diseases, has unveiled the selection of its present Board member, Hyung Heon ("H.H.") Kim, as the newly instated Chief Executive Officer and President. In his new role, Mr. Kim takes the helm from Joseph Hooker, who assumed the position of interim Chief Executive Officer and President in January 2023.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page